Steven D Rubin Eloxx Pharmaceuticals, Inc. (ELOX) insider trading activity

ELOX Quotes by TradingView

Steven D Rubin is Director of Eloxx Pharmaceuticals, Inc.. Currently has a direct ownership of 15,750 shares of ELOX, which is worth approximately $0. The most recent transaction as insider was on Jan 24, 2025, when has been sold 3,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.8K
31.25% 3M change
n/a 12M change
Total Value Held $0

Steven D Rubin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 24 2025
BUY
Exercise of conversion of derivative security
-
3,750 Added 19.23%
15,750 Common Stock
Oct 16 2024
BUY
Grant, award, or other acquisition
-
12,000 Added 50.0%
12,000 Common Stock

Also insider at

OPK
OPKO HEALTH, INC. Healthcare
Executive VP-Administration
RDVT
Red Violet, Inc. Technology
CDXC
ChromaDex Corp. Healthcare
Director
COCP
Cocrystal Pharma, Inc. Healthcare
Director
SDR

Steven D Rubin

Director
Miami,, FL

Track Institutional and Insider Activities on ELOX

Follow Eloxx Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELOX shares.

Notify only if

Insider Trading

Get notified when an Eloxx Pharmaceuticals, Inc. insider buys or sells ELOX shares.

Notify only if

News

Receive news related to Eloxx Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ELOX